Abstract | AIM: METHOD: Eight patients with RP and foveal cystic-appearing lesions observed on fundus examination and by optical coherence tomography (OCT) testing were treated with a topical form of carbonic anhydrase inhibitor. RESULTS: Foveal cystic-like spaces were documented by OCT testing in all eight patients before treatment. All patients had a significant reduction in their foveal thickness (FT) and foveal zone thickness (FZT) in at least one eye after using 2% dorzolamide three times a day for 1 or 2 months. Six patients had an improvement in both eyes. After an additional 6-13 months of the same treatment regimen, out of six patients who had a sustained reduction in FT and FZT in at least one eye, four had this reduction in both eyes. While they were still taking Trusopt, a recurrence (rebound) of CME in both eyes was observed in two patients, whereas one patient had a sustained improvement in one eye and rebound of CME in the other eye. Out of 8 patients, 3 showed an improvement in their visual acuity by > or =7 letters, in at least one eye, on Snellen acuity charts, which was determined as clinically significant. CONCLUSION: Results from this study suggest that patients with RP could potentially sustain a beneficial effect from continued treatment with a topical form of carbonic anhydrase inhibitor.
|
Authors | Gerald A Fishman, Marsha A Apushkin |
Journal | The British journal of ophthalmology
(Br J Ophthalmol)
Vol. 91
Issue 6
Pg. 743-5
(Jun 2007)
ISSN: 0007-1161 [Print] England |
PMID | 17215269
(Publication Type: Clinical Trial, Journal Article, Research Support, N.I.H., Extramural, Research Support, Non-U.S. Gov't)
|
Chemical References |
- Carbonic Anhydrase Inhibitors
- Sulfonamides
- Thiophenes
- dorzolamide
|
Topics |
- Carbonic Anhydrase Inhibitors
(therapeutic use)
- Drug Administration Schedule
- Follow-Up Studies
- Fovea Centralis
(pathology)
- Humans
- Macular Edema
(drug therapy, etiology, pathology, physiopathology)
- Prospective Studies
- Retinitis Pigmentosa
(complications)
- Sulfonamides
(therapeutic use)
- Thiophenes
(therapeutic use)
- Tomography, Optical Coherence
- Treatment Outcome
- Visual Acuity
|